LEADER 02206nam  2200493   450 
001 9910464565203321
005 20170821194729.0
010   $a1-60805-856-5
035   $a(CKB)3710000000121780
035   $a(EBL)1704826
035   $a(SSID)ssj0001293283
035   $a(PQKBManifestationID)11734656
035   $a(PQKBTitleCode)TC0001293283
035   $a(PQKBWorkID)11304379
035   $a(PQKB)10473968
035   $a(MiAaPQ)EBC1704826
035   $a(EXLCZ)993710000000121780
100   $a20140701h20142014  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aFrontiers in clinical drug research$hVolume 1 $eDiabetes and obesity /$fAtta-ur-Rahman, editor ; contributors Agustin Busta [and fourteen others]
210  1$aSharjah, United Arab Emirates :$cBentham Science Publishers,$d2014.
210  4$dİ[2014]
215   $a1 online resource (316 p.)
300   $aIncludes index.
311   $a1-60805-857-3 
327   $a01 Cover.pdf; 02 Title Page; 03 Revised EUL 24-02-14; 04 Table of Content; 06 Preface; 07 list of contributor; 08 CH-01; 09 CH-02; 10 CH-03; 11 CH-04; 12 CH-05; 13 CH-06; 14 Index
330   $aFrontiers in Clinical Drug Research - Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinica
606   $aMetabolism$xDisorders
608   $aElectronic books.
615  0$aMetabolism$xDisorders.
676   $a616.39
702   $aRahman$b Atta-ur
702   $aBusta$b Agustin
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910464565203321
996   $aFrontiers in clinical drug research$92109357
997   $aUNINA